Wednesday, Dec 6, 2023
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Education Today
    • Reviews
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | India | Zydus Commences Supply Of Covid 19 Vaccine Zycov D To Central Govt

Zydus commences supply of COVID-19 vaccine ZyCoV-D to Central govt

Ahmedabad: Pharmaceutical company Zydus on Wednesday announced that it has started the supplies of its COVID-19 vaccine ZyCoV-D to the Government of India against their order from its newly commissioned state-of-the-art, Zydus Vaccine Technology Excellence Centre at the Zydus Biotech Park in Changodar, Ahmedabad. The company is also planning to make the vaccine available in […]

By ANI
Published Date - 11:04 AM, Wed - 2 February 22
Zydus commences supply of COVID-19 vaccine ZyCoV-D to Central govt
whatsapp facebook twitter telegram

Ahmedabad: Pharmaceutical company Zydus on Wednesday announced that it has started the supplies of its COVID-19 vaccine ZyCoV-D to the Government of India against their order from its newly commissioned state-of-the-art, Zydus Vaccine Technology Excellence Centre at the Zydus Biotech Park in Changodar, Ahmedabad.

The company is also planning to make the vaccine available in the private market.
ZyCoV-D is a three-dose vaccine administered intradermally using the painless PharmaJet(r) needle-free system, Tropis(r), on day 0, day 28 and day 56.


The vaccine will be priced at Rs 265 per dose and the applicator being offered at Rs 93 per dose excluding GST Zydus VTEC manufactures the drug substance for the needle-free DNA Plasmid vaccine, ZyCoV-D. The manufacturing process and in-process material transfers within the plant are automated.

Zydus has also entered into a definitive agreement with Shilpa Medicare Limited, a contract manufacturing organization to produce mutually agreeable doses of ZyCoV-D.
The company also entered into an agreement with Enzychem Lifesciences of the Republic of Korea for the manufacturing license and technology transfer for the Plasmid DNA Vaccine.

  • Follow Us :
  • Tags
  • Enzychem Lifesciences
  • GST Zydus VTEC
  • Zydus

Related News

  • Zydus’ Virafin gets emergency use approval for treating moderate COVID-19 cases

    Zydus’ Virafin gets emergency use approval for treating moderate COVID-19 cases

  • Indian drug firms recall various products in US market

    Indian drug firms recall various products in US market

Latest News

  • Fifties by Wyatt, Sciver-Brunt fire England Women to 197/6

    4 mins ago
  • Seven MP seats from Telangana to fall vacant soon

    19 mins ago
  • RR’s Nithya rules the waters with five gold medals

    22 mins ago
  • Rs.500 LPG promise: Nizamabad women throng gas agencies to update KYC

    25 mins ago
  • Ambedkar death anniversary celebrated in NTPC Ramagundam

    20 mins ago
  • SCCL trade union polls: Young leadership to be tasked with decisive role

    34 mins ago
  • BRS will play role of responsible opposition: KTR

    35 mins ago
  • Revanth Reddy invites people of Telangana to swearing-in ceremony

    40 mins ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam